The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia.
about
Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia.Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia.Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia.Integration of Next-Generation Sequencing to Treat Acute Lymphoblastic Leukemia with Targetable Lesions: The St. Jude Children's Research Hospital Approach.WT1 loss attenuates the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemia.Mutant JAK3 signaling is increased by loss of wild type JAK3 or by acquiring secondary JAK3 mutations in T-ALL.Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma.Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia.Acute lymphoblastic leukaemia in 2017: Immunotherapy for ALL takes the world by storm.Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system.ZFP36L2 is a cell cycle-regulated CCCH protein necessary for DNA lesion-induced S-phase arrest.Enhancer dysfunction in leukemia.Drugging DNA repair to target T-ALL cells.A novel AGGF1-PDGFRb fusion in pediatric T-cell acute lymphoblastic leukemia.Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia.Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia.Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia.The Role of TAL1 in Hematopoiesis and Leukemogenesis.Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia.Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models.Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation.Dysregulated transcriptional networks in and -rearranged T-ALLThe genetic basis and cell of origin of mixed phenotype acute leukaemiaLmo2 expression defines tumor cell identity during T-cell leukemogenesisUSP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemiaAnalysis of Racial/Ethnic Representation in Select Basic and Applied Cancer Research StudiesHigh-dose methotrexate vs. Capizzi methotrexate for the treatment of childhood T-cell acute lymphoblastic leukemiaCooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia
P2860
Q38602949-33046DB0-01DC-4431-A8CB-19C0369AD937Q41660964-60FE80D6-4335-422A-A11C-325DF46425DDQ42369939-D5A02245-CA58-4844-A73F-5B936FCE221BQ47096152-49BE8C7B-098B-47FE-8671-E970EF1A861EQ47369729-5926E43B-148C-4AE0-BE7B-790E39920801Q47395580-3C3E925B-9DAF-4128-8673-5B8DFA3C489BQ48139301-20BAB9FE-CA6C-4AC3-8B6D-6457635B7375Q49568203-673ABCA3-25B2-4513-A81E-44D990181ED0Q49644228-48431E51-914B-45C7-B8E7-C35273CF775EQ49900857-49E6A694-E912-4A03-B8C9-255752071204Q49961554-F860EFEE-59B1-4AFD-8ED9-B0C1DDFB321BQ50028355-8F484E9E-A75F-46C9-86A2-ACC16C45F75AQ50110532-AF13CD31-3843-419C-8B4F-D24A309D0A6AQ50327439-354E893C-C494-4330-A6B7-BBE0B7F472FFQ52431551-C9E76E42-7EF0-4DFF-B7A4-F85D43D624FEQ52717677-F71DB3AB-68B0-48A5-9E19-24F63059ADB6Q52729895-15F4A316-20F0-447E-8842-7DF313B7E82AQ53703572-2F5EB9E7-1095-42DE-B551-FE5C7E2B69DEQ54113323-1ABD1273-8D2A-41C7-93B7-6677459661A1Q54963328-9C05B415-E6F7-4AE5-89C7-28FFEB859C0AQ55088548-965B1990-61CB-4B95-93F6-5005D007C720Q55116387-540B8CB5-29A8-4614-BC70-BC8839830EE9Q56518873-ED0DCB59-4421-4D4F-B542-B218604CA266Q57158107-8E865273-11EB-4F13-B42A-AE13F0498B26Q58051449-0AE4AE65-7DD4-4FE2-91DD-BCE7A4BC65E7Q58116419-7F0F8A91-CC20-420F-8EC9-BCFD067B4FC0Q58726581-6D9E0A8B-832A-41EF-9C3D-426646A63563Q58776389-BF2EDBEF-F6B4-488F-B1EF-8493765AF9B4Q58785945-15AEDBAF-D8B9-4A1E-AD27-0FF13D755E27
P2860
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The genomic landscape of pedia ...... acute lymphoblastic leukemia.
@en
The genomic landscape of pedia ...... acute lymphoblastic leukemia.
@nl
type
label
The genomic landscape of pedia ...... acute lymphoblastic leukemia.
@en
The genomic landscape of pedia ...... acute lymphoblastic leukemia.
@nl
prefLabel
The genomic landscape of pedia ...... acute lymphoblastic leukemia.
@en
The genomic landscape of pedia ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P50
P356
P1433
P1476
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
@en
P2093
Andrew J Carroll
Brent L Wood
Brian P Sorrentino
Cheng Cheng
Cheryl L Willman
Daniela S Gerhard
Deqing Pei
Edgar Sioson
Elizabeth Raetz
Jaime Guidry Auvil
P2860
P2888
P304
P356
10.1038/NG.3909
P407
P50
P577
2017-07-03T00:00:00Z
P6179
1090336724